CSC’s underwriting solution, Mortality Assessment Technology (MAT), is a revolutionary scientific predictive mortality assessment tool from BioSignia that uses a patented predictive analytics model to accurately assess mortality risk and safely increase preferred risk categorizations using common underwriting data. It applies advanced predictive technology and evidence-based medical science to provide quantitative mortality assessments consistently and objectively, using input values that are routinely captured and assessed in medically underwritten applications.
Let users know what you would have wanted to know about this company.